PRISM MediaWire

Medical Devices

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery

22 January 2024

Blue Water Petroleum Corp (BWPC) Develops New Battery Products

CHEYENNE, WY, January 16, 2024 - PRISM MediaWire - Blue Water Petroleum Corp’s (OTC PINK: BWPC) owned subsidiary Attimar SA, has announced the development of a new battery technology, delivering up to a twenty-five percent increase in charging capacity and up to a ten ti...

16 January 2024

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

Mr. McCarrey brings a strong track record of success and deep experience in regenerative medicine markets

11 January 2024

SS Innovations Achieves Significant Milestones in 2023

Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures

8 January 2024

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent

25 December 2023

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Granted Two Orphan Drug Designations by FDA

20 December 2023

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

POMPANO BEACH, FLORIDA, December 19, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

19 December 2023

CMS Establishes National Pricing for BioStem Technologies Product AmnioWrap2™

“This change means that AmnioWrap2™ (AW2) can now be offered to all Medicare providers throughout the country. BioStem Technologies is taking the lead in wound care innovation, leveraging our distinctive BioRetain® process. This is more than a breakthrough; it's a transf...

14 December 2023

Center for Medicare Services Established National Pricing of AmnioWrap2(TM)in All MAC Regions

Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions

14 December 2023

BioStem Technologies Appoints Industry Veteran, Thomas Dugan to Board of Directors

New York, December 13, 2023 - BioStem Technologies (OTC: BSEM) has announced the appointment of Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to the role, with proven, hands-on expertise as a senior executive who has ex...

13 December 2023